Complete Remission of Diabetes with a Transient HDAC Inhibitor and Insulin in Streptozotocin Mice

Researchers showed that eliminating abnormal bone marrow-derived cells using bone marrow transplantation resulted in controlling serum glucose in diabetic mice, in which normoglycemia was sustained even after cessation of insulin therapy.